Literature DB >> 230514

Inhibition of cis-platinum nephrotoxicity by diethyldithiocarbamate rescue in a rat model.

R F Borch, M E Pleasants.   

Abstract

The nephrotoxic effects of cis-dichlorodiammineplatinum(II) (NSC-119875) administered to male F344 rats at the median lethal dose (LD50; 7.5 mg/kg) were inhibited by treatment with sodium diethyldithiocarbamate (500 or 750 mg/kg) between 1 and 4 hr after cis-platinum administration. Those animals receiving cis-platinum alone had mean serum blood urea nitrogen levels of 234 mg/dl at the time of maximal toxicity (day 5); kidney sections revealed large areas of degeneration and necrosis. When dithiocarbamate rescue was carried out after cis-platinum treatment, mean blood urea nitrogen levels were in the range 56-95 mg/dl; kidney sections were grossly normal with a barely discernible band of degeneration at the corticomedullary junction. Gastrointestinal toxicity was observed in greater than 95% of the cis-platinum-treated rats but was totally absent in those receiving subsequent rescue treatment. A significant decrease in weight loss was also observed in the dithiocarbamate-rescued rats. Based on the chemistry of platinum-sulfur interactions and the observed time-dependence of the rescue treatment, it is suggested that dithiocarbamate exerts its effects via competitive chelation and removal of platinum coordinated to protein-bound sulfhydryl groups of the kidney tubule cells.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 230514      PMCID: PMC411916          DOI: 10.1073/pnas.76.12.6611

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  20 in total

1.  Effects of the mercurial diuretic, mersalyl, on the concentration of protein-bound sulfhydryl in the cytoplasm of dog kidney cells.

Authors:  E J CAFRUNY; A FARAH
Journal:  J Pharmacol Exp Ther       Date:  1956-05       Impact factor: 4.030

2.  Comparative nephrotoxicity of platinum cancer chemotherapeutic agents.

Authors:  J M Ward; D M Young; K A Fauvie; M K Wolpert; R Davis; A M Guarino
Journal:  Cancer Treat Rep       Date:  1976-11

3.  Mercury nephrotoxicity in the rat. 1. Factors influencing the localization of the tubular lesions.

Authors:  A E RODIN; C N CROWSON
Journal:  Am J Pathol       Date:  1962-09       Impact factor: 4.307

Review 4.  The role of cis-platinum in solid-tumor therapy.

Authors:  L H Einhorn; S D Williams
Journal:  N Engl J Med       Date:  1979-02-08       Impact factor: 91.245

5.  The treatment of acute nickel carbonyl poisoning with sodium diethyldithiocarbamate.

Authors:  F W Sunderman
Journal:  Ann Clin Res       Date:  1971-06

6.  Plasma levels and urinary excretion of filterable platinum species following bolus injection and iv infusion of cis-dichlorodiammineplatinum(II) in man.

Authors:  T F Patton; K J Himmelstein; R Belt; S J Bannister; L A Sternson; A J Repta
Journal:  Cancer Treat Rep       Date:  1978-09

7.  Immunopotentiation and anabolism induced by sodium diethyldithiocarbamate.

Authors:  G Renoux; M Renoux
Journal:  J Immunopharmacol       Date:  1979

8.  A method for the determination of tetraethylthiuram disulphide (Antabus, Abstinyl) and diethyldithiocarbamate in blood and urine; some studies on the metabolism of tetraethylthiuram disulphide.

Authors:  H LINDERHOLM; K BERG
Journal:  Scand J Clin Lab Invest       Date:  1951       Impact factor: 1.713

9.  Thiourea reverses cross-links and restores biological activity in DNA treated with dichlorodiaminoplatinum (II).

Authors:  J Filipski; K W Kohn; R Prather; W M Bonner
Journal:  Science       Date:  1979-04-13       Impact factor: 47.728

10.  Long term effect of cis-diamminedichloride platinum (CDDP) on renal function and structure in man.

Authors:  M Dentino; F C Luft; M N Yum; S D Williams; L H Einhorn
Journal:  Cancer       Date:  1978-04       Impact factor: 6.860

View more
  36 in total

1.  Experimental verification of protective effect of hydrogen-rich water against cisplatin-induced nephrotoxicity in rats using dynamic contrast-enhanced CT.

Authors:  A Kitamura; S Kobayashi; T Matsushita; H Fujinawa; K Murase
Journal:  Br J Radiol       Date:  2010-06       Impact factor: 3.039

2.  The effects of cisplatin on the concentration of protein thiols and glutathione in the rat kidney.

Authors:  P Mistry; Y Merazga; D J Spargo; P A Riley; D C McBrien
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

3.  Experimental verification of age-dependent cisplatin-induced nephrotoxicity in rats using dynamic contrast-enhanced computed tomography.

Authors:  Atsushi Tachibana; Ayumu Nagasawa; Akihiro Kitamura; Shohei Miyazaki; Kenya Murase
Journal:  Jpn J Radiol       Date:  2010-02-26       Impact factor: 2.374

4.  Intracellular metabolites of cisplatin in the rat kidney.

Authors:  P Mistry; C Lee; D C McBrien
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

5.  Effects of the diuretics mannitol or acetazolamide on nephrotoxicity and physiological disposition of cisplatin in rats.

Authors:  N M Osman; M P Copley; C L Litterst
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

6.  The effects of dimercaptosuccinic acid and other chelating agents on the retention of platinum in the rat kidney after treatment with cisplatin.

Authors:  F Planas-Bohne; E Shand; D M Taylor
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

7.  Protective effect of piperacillin against the nephrotoxicity of cisplatin in rats.

Authors:  T Hayashi; Y Watanabe; K Kumano; R Kitayama; T Muratani; T Yasuda; I Saikawa; J Katahira; T Kumada; K Shimizu
Journal:  Antimicrob Agents Chemother       Date:  1989-04       Impact factor: 5.191

8.  Effect of diethyldithiocarbamate rescue on tumor response to cis-platinum in a rat model.

Authors:  R F Borch; J C Katz; P H Lieder; M E Pleasants
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

9.  Mechanistic comparison of human high-affinity copper transporter 1-mediated transport between copper ion and cisplatin.

Authors:  Zheng D Liang; David Stockton; Niramol Savaraj; Macus Tien Kuo
Journal:  Mol Pharmacol       Date:  2009-07-01       Impact factor: 4.436

10.  Hyperuricemia and hypoalbuminemia predispose to cisplatin-induced nephrotoxicity.

Authors:  A A Nanji; D J Stewart; N Z Mikhael
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.